Editorial team profile
iMedix Editorial Team
- Headquarters:New York, United States
iMedix channels
Background
About iMedix Editorial Team
The iMedix Editorial Team is dedicated to delivering accurate, evidence-based medical information. We enforce strict quality standards to ensure all content aligns with current clinical protocols and regulatory safety guidance. Our goal is to empower readers with reliable educational data, not to provide personal medical advice.
Editorial contributions
Published work
Content published under the iMedix Editorial Team byline.
Kenya Confirms First Case as Bundibugyo Ebola Outbreak Becomes the Second-Largest on Record
Kenya has confirmed its first case of Ebola disease caused by Bundibugyo virus, the strain behind the outbreak declared in the Democratic Republic of the Congo...
FDA Approves Tukysa as a Chemotherapy-Free Maintenance Option for HER2-Positive Metastatic Breast Cancer
Tucatinib (Tukysa), an oral HER2-targeted drug, can now be used earlier in the treatment of advanced HER2-positive breast cancer. The FDA has approved it, together with...
FDA Approves Tavapadon (Juvmo), a Dopamine Agonist With a New Target for Parkinson’s Disease
The FDA has approved tavapadon, sold as Juvmo, a once-daily tablet for adults with Parkinson’s disease. The agency’s list of novel drug approvals dates the decision...
Florida Dengue Outbreak Tops 250 Local Cases, With Tampa Bay at the Center
Florida’s outbreak of locally acquired dengue has not slowed. The state’s weekly surveillance report for September 20–26 counts 252 cases this year in people who caught...